For the first time, WHO’s treatment tips include a clear recommendation for the usage of extensive-acting injectable cabotegravir and rilpivirine (Taxi/RPV) as a substitute switching selection for antiretroviral therapy (ART) for Grownups and adolescents that have obtained whole viral suppression on oral ART and would not have Lively hepatitis B https://g.page/r/CSLr2xzoMfbHEBM